Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 11, 2020
Gastrointestinal diseases and their impact on drug solubility: Crohn's disease
Angela Effinger, Caitriona M O'Driscoll, Mark McAllister, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 9, 2020
Predicting budesonide performance in healthy subjects and patients with Crohn's disease using biorelevant in vitro dissolution testing and PBPK modeling
Angela Effinger, Caitriona M O'Driscoll, Mark McAllister, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 10, 2020
Gastrointestinal diseases and their impact on drug solubility: Celiac disease
Angela Effinger, Caitriona M O'Driscoll, Mark McAllister, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 13, 2016
Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies
Elise Grignard, Robert Taylor, Mark McAllister, et al.
Frontiers in Medicine
|
March 22, 2021
Leveraging Oral Drug Development to a Next Level: Impact of the IMI-Funded OrBiTo Project on Patient Healthcare
Bart Hens, Patrick Augustijns, Hans Lennernäs, et al.
Developmental and Comparative Immunology
|
January 20, 2019
Teleost antimicrobial peptide hepcidin contributes to host defense of goldfish (Carassius auratus L.) against Trypanosoma carassii
Jiasong Xie, Victory Obiefuna, Jordan W Hodgkinson, et al.
Drug Delivery and Translational Research
|
November 20, 2024
A quality by design strategy for cocrystal design based on novel computational and experimental screening strategies: part A
Steven A Ross, Adam Ward, Patricia Basford, et al.
The Journal of Pharmacy and Pharmacology
|
September 12, 2018
The impact of food intake on the luminal environment and performance of oral drug products with a view to in vitro and in silico simulations: a PEARRL review
Christina Pentafragka, Mira Symillides, Mark McAllister, et al.
Molecular Pharmaceutics
|
April 10, 2023
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An <i>In Vivo</i>-<i>In Vitro</i>-<i>In Silico</i> Approach
Joseph Piscitelli, Bart Hens, Irena Tomaszewska, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 2, 2020
The use of PBPK/PD to establish clinically relevant dissolution specifications for zolpidem immediate release tablets
Rafael L M Paraiso, Rachel H Rose, Nikoletta Fotaki, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 11, 2020
Gastrointestinal diseases and their impact on drug solubility: Crohn's disease
Angela Effinger, Caitriona M O'Driscoll, Mark McAllister, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 9, 2020
Predicting budesonide performance in healthy subjects and patients with Crohn's disease using biorelevant in vitro dissolution testing and PBPK modeling
Angela Effinger, Caitriona M O'Driscoll, Mark McAllister, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 10, 2020
Gastrointestinal diseases and their impact on drug solubility: Celiac disease
Angela Effinger, Caitriona M O'Driscoll, Mark McAllister, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 13, 2016
Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies
Elise Grignard, Robert Taylor, Mark McAllister, et al.
Frontiers in Medicine
|
March 22, 2021
Leveraging Oral Drug Development to a Next Level: Impact of the IMI-Funded OrBiTo Project on Patient Healthcare
Bart Hens, Patrick Augustijns, Hans Lennernäs, et al.
Developmental and Comparative Immunology
|
January 20, 2019
Teleost antimicrobial peptide hepcidin contributes to host defense of goldfish (Carassius auratus L.) against Trypanosoma carassii
Jiasong Xie, Victory Obiefuna, Jordan W Hodgkinson, et al.
Drug Delivery and Translational Research
|
November 20, 2024
A quality by design strategy for cocrystal design based on novel computational and experimental screening strategies: part A
Steven A Ross, Adam Ward, Patricia Basford, et al.
The Journal of Pharmacy and Pharmacology
|
September 12, 2018
The impact of food intake on the luminal environment and performance of oral drug products with a view to in vitro and in silico simulations: a PEARRL review
Christina Pentafragka, Mira Symillides, Mark McAllister, et al.
Molecular Pharmaceutics
|
April 10, 2023
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An <i>In Vivo</i>-<i>In Vitro</i>-<i>In Silico</i> Approach
Joseph Piscitelli, Bart Hens, Irena Tomaszewska, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 2, 2020
The use of PBPK/PD to establish clinically relevant dissolution specifications for zolpidem immediate release tablets
Rafael L M Paraiso, Rachel H Rose, Nikoletta Fotaki, et al.
Page
of 6